Cargando…
Retraction Note to: Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation
Autores principales: | Gao, Jin, Yuan, Yuan, Zhang, Lili, Yu, Shaorong, Lu, Jianwei, Feng, Jifeng, Hu, Sainan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798271/ https://www.ncbi.nlm.nih.gov/pubmed/33430826 http://dx.doi.org/10.1186/s12935-021-01759-5 |
Ejemplares similares
-
Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation
por: Gao, Jin, et al.
Publicado: (2020) -
[Retracted] MicroRNA‑708 inhibits the proliferation and invasion of osteosarcoma cells by directly targeting ZEB1
por: He, Jun, et al.
Publicado: (2023) -
MicroRNA-200b Acts as a Tumor Suppressor in Osteosarcoma via Targeting ZEB1 [Retraction]
Publicado: (2021) -
MicroRNA-643 regulates the expression of ZEB1 and inhibits tumorigenesis in osteosarcoma
por: Wang, Huan, et al.
Publicado: (2022) -
Retraction statement: MicroRNA‐431 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the ZEB1‐mediated epithelial–mesenchymal transition
Publicado: (2022)